Evidence map›Paper›PMID 34706137›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Synthesis of (±)-Setigerumine I: Biosynthetic Origins of the Elusive Racemic Papaveraceae Isoxazolidine Alkaloids*.

Ana V Serna, László Kürti, Juha H Siitonen

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Study of Cytotoxicity of Pyrrolo[3,4-International journal of molecular sciences · 2026
    Article
  2. Review
  3. Intramolecular N-O Bond Formation for the Synthesis ofJournal of the American Chemical Society · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Ana V SernaDepartment of Chemistry, Rice University, 6500 Main Street, Houston, TX, 77030, USA.ORCID 0000-0003-4395-5678
László KürtiDepartment of Chemistry, Rice University, 6500 Main Street, Houston, TX, 77030, USA.ORCID 0000-0002-9634-7038
Juha H SiitonenDepartment of Chemistry, Rice University, 6500 Main Street, Houston, TX, 77030, USA.ORCID 0000-0002-9816-637X

Funding

New catalytic methods for the rapid synthesis of N-unprotected chiral aziridines and aminesR35GM136373 · NIGMS · RICE UNIVERSITY · PI KURTI, LASZLO · 2020 to 2024
$2.1M
National Science Foundation, Division of Chemistry CHE-2102462NIGMS NIH HHS R35 GM-136373NIGMS NIH HHS R35 GM136373Osk. Huttusen säätiöWelch Foundation C-1764Zevi & Bertha Salsburg Memorial Fellowship
6 · The paper itself

Abstract

The biosynthetic origins of the structurally related racemic isoxazolidine Papaveraceae alkaloids Setigerumine I, Dactylicapnosinine and Dactylicapnosine have remained elusive since their original isolation over two decades ago. Herein we report the first biosynthetic hypothesis for their formation and, inspired by it, the first synthesis of (±)-Setigerumine I with accompanying computational rationale. Based on the results, these isoxazolidine alkaloids arise from racemizing oxidative rearrangements of prominent isoquinoline alkaloids Noscapine and Hydrastine. The key steps featured in this synthesis are a room temperature Cope elimination and a domino oxidation/inverse-electron demand 1,3-dipolar cycloaddition of an axially chiral, yet configurationally unstable, intermediate. The work opens this previously inaccessible family of natural products for biological studies.

Indexed as

AlkaloidsCycloaddition ReactionIsoxazolesOxidation-ReductionAlkaloidsIsoxazolesalkaloidsbiomimetic synthesisdipolar cycloadditionrearrangementtotal synthesis

Identifiers

PMID34706137
PMCPMC8932159

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.